Charcot-Marie-Tooth disease: genes and variants
Explore variant evidence for Charcot-Marie-Tooth disease across 8 analyzed proteins (LMNA, MFN2, GJB1, PMP22, TTR and 3 more). Linked ClinVar records include 321 pathogenic or likely pathogenic variants, 1,085 variants of uncertain significance and 214 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Charcot-Marie-Tooth disease
LMNA: Prelamin-A/C
The gene product produces lamins A and C, structural proteins that form the nuclear lamina beneath the inner nuclear membrane. Lamins help maintain nuclear shape and organize chromatin, and LMNA variants are associated with muscular dystrophy, cardiomyopathy, lipodystrophy, and premature-aging syndromes.
130 ClinVar pathogenic / likely pathogenic and 524 uncertain variants in LMNA have source records linked to Charcot-Marie-Tooth disease. Association strength is not clinical gene validity.
MFN2: Mitofusin-2
It promotes outer-mitochondrial-membrane fusion and coordinates mitochondrial transport, distribution, and contacts with other organelles. Pathogenic variants are a major cause of Charcot-Marie-Tooth disease type 2A and related axonal neuropathies.
101 ClinVar pathogenic / likely pathogenic and 494 uncertain variants in MFN2 have source records linked to Charcot-Marie-Tooth disease. Association strength is not clinical gene validity.
GJB1: Gap junction beta-1 protein
It forms connexin 32 channels that support metabolic and signaling communication across layers of peripheral myelin produced by Schwann cells. Pathogenic variants cause X-linked Charcot-Marie-Tooth disease type 1, often with transient central nervous system manifestations in some individuals.
54 ClinVar pathogenic / likely pathogenic and 155 uncertain variants in GJB1 have source records linked to Charcot-Marie-Tooth disease. Association strength is not clinical gene validity.
PMP22: Peripheral myelin protein 22
Its dosage is critical for normal Schwann-cell myelin formation and stability in peripheral nerves. Duplication causes Charcot-Marie-Tooth disease type 1A, deletion causes hereditary neuropathy with liability to pressure palsies, and point variants cause additional neuropathies.
30 ClinVar pathogenic / likely pathogenic and 94 uncertain variants in PMP22 have source records linked to Charcot-Marie-Tooth disease. Association strength is not clinical gene validity.
TTR: Transthyretin
Its tetramer transports thyroxine and retinol-binding protein, but destabilization can expose aggregation-prone monomers. Pathogenic variants cause hereditary transthyretin amyloidosis affecting peripheral nerves and heart, while wild-type protein can also form cardiac amyloid with aging.
3 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in TTR have source records linked to Charcot-Marie-Tooth disease. Association strength is not clinical gene validity.
VCP: Transitional endoplasmic reticulum ATPase
It uses ATP to extract ubiquitinated proteins from complexes or membranes for recycling or degradation and is central to proteostasis, ER-associated degradation, and autophagy. Dominant pathogenic variants cause multisystem proteinopathy with inclusion-body myopathy, Paget disease, frontotemporal dementia, or ALS.
2 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in VCP have source records linked to Charcot-Marie-Tooth disease. Association strength is not clinical gene validity.
KIF5A: Kinesin heavy chain isoform 5A
It drives anterograde transport of organelles and proteins along axonal microtubules and is especially important in long motor neurons. Pathogenic variants can cause hereditary spastic paraplegia, axonal Charcot-Marie-Tooth disease, or amyotrophic lateral sclerosis depending on the affected region and mechanism.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KIF5A have source records linked to Charcot-Marie-Tooth disease. Association strength is not clinical gene validity.
NTRK1: High affinity nerve growth factor receptor
Nerve-growth-factor signaling through this pathway supports survival and differentiation of sensory and sympathetic neurons. Loss-of-function variants cause congenital insensitivity to pain with anhidrosis, whereas oncogenic NTRK1 fusions can drive diverse cancers.
0 ClinVar pathogenic / likely pathogenic and 8 uncertain variants in NTRK1 have source records linked to Charcot-Marie-Tooth disease. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): SETX, ATP1A1, POLG, DNMT1, ATP7A, COL6A2, GABRG2, GLA and 1 more.
Where Charcot-Marie-Tooth disease variants cluster
- MFN2 Dynamin-type G (positions 93–342): 66 of 101 ClinVar pathogenic / likely pathogenic variants, 2.0× more than its size predicts (a length-based count, not a validated hotspot).
- LMNA Coil 1A (positions 34–70): 22 of 124 ClinVar pathogenic / likely pathogenic variants, 3.2× more than its size predicts (a length-based count, not a validated hotspot).
- MFN2 Part of a helix bundle domain, formed by helices (positions 359–385): 13 of 101 ClinVar pathogenic / likely pathogenic variants, 3.6× more than its size predicts (a length-based count, not a validated hotspot).
- LMNA Head (positions 1–33): 14 of 124 ClinVar pathogenic / likely pathogenic variants, 2.3× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Charcot-Marie-Tooth disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MFN2 A738V | 738 | Coiled coil | Pathogenic / likely pathogenic (★★★★) |
| PMP22 T23R | 23 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB1 R15Q | 15 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GJB1 R164W | 164 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB1 R183C | 183 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB1 R183S | 183 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB1 R183H | 183 | Extracellular | Pathogenic / likely pathogenic (★★) |
| LMNA R25G | 25 | Head | Pathogenic / likely pathogenic (★★) |
| LMNA R25C | 25 | Head | Pathogenic / likely pathogenic (★★) |
| LMNA R25H | 25 | Head | Pathogenic / likely pathogenic (★★) |
| LMNA R28W | 28 | Head | Pathogenic / likely pathogenic (★★) |
| LMNA R41H | 41 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA R62C | 62 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA L92F | 92 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA R190Q | 190 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA R190W | 190 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA R453W | 453 | LTD | Pathogenic / likely pathogenic (★★) |
| LMNA R541C | 541 | LTD | Pathogenic / likely pathogenic (★★) |
| LMNA R541S | 541 | LTD | Pathogenic / likely pathogenic (★★) |
| LMNA R541H | 541 | LTD | Pathogenic / likely pathogenic (★★) |
| MFN2 I88T | 88 | Part of a helix bundle domain, formed by helices | Pathogenic / likely pathogenic (★★) |
| MFN2 R94W | 94 | Dynamin-type G | Pathogenic / likely pathogenic (★★) |
| MFN2 R94G | 94 | Dynamin-type G | Pathogenic / likely pathogenic (★★) |
| MFN2 T105M | 105 | Dynamin-type G | Pathogenic / likely pathogenic (★★) |
| MFN2 H165Y | 165 | Dynamin-type G | Pathogenic / likely pathogenic (★★) |
| MFN2 I213N | 213 | Dynamin-type G | Pathogenic / likely pathogenic (★★) |
| MFN2 V244M | 244 | Dynamin-type G | Pathogenic / likely pathogenic (★★) |
| MFN2 R259L | 259 | Dynamin-type G | Pathogenic / likely pathogenic (★★) |
| MFN2 R259C | 259 | Dynamin-type G | Pathogenic / likely pathogenic (★★) |
| MFN2 R280H | 280 | Dynamin-type G | Pathogenic / likely pathogenic (★★) |
| MFN2 R280C | 280 | Dynamin-type G | Pathogenic / likely pathogenic (★★) |
| MFN2 H361Q | 361 | Part of a helix bundle domain, formed by helices | Pathogenic / likely pathogenic (★★) |
| MFN2 R364P | 364 | Part of a helix bundle domain, formed by helices | Pathogenic / likely pathogenic (★★) |
| MFN2 R364W | 364 | Part of a helix bundle domain, formed by helices | Pathogenic / likely pathogenic (★★) |
| MFN2 M376R | 376 | Part of a helix bundle domain, formed by helices | Pathogenic / likely pathogenic (★★) |
| MFN2 L724P | 724 | Coiled coil | Pathogenic / likely pathogenic (★★) |
| MFN2 W740S | 740 | Part of a helix bundle domain, formed by helices | Pathogenic / likely pathogenic (★★) |
| PMP22 H12R | 12 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PMP22 H12Q | 12 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PMP22 T23K | 23 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PMP22 M69K | 69 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PMP22 S72L | 72 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PMP22 S72W | 72 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PMP22 S79T | 79 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PMP22 G150D | 150 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PMP22 G150V | 150 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PMP22 G150R | 150 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PMP22 G150C | 150 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB1 R15P | 15 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GJB1 R15W | 15 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GJB1 R15L | 15 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GJB1 R164L | 164 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB1 V177M | 177 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB1 R183P | 183 | Extracellular | Pathogenic / likely pathogenic (★★) |
| LMNA M1I | 1 | Head | Pathogenic / likely pathogenic (★★) |
| LMNA R28Q | 28 | Head | Pathogenic / likely pathogenic (★★) |
| LMNA E31K | 31 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA K32E | 32 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA N39D | 39 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA R48P | 48 | IF rod | Pathogenic / likely pathogenic (★★) |
Showing 60 of 321.
Uncertain variants prioritized for review in Charcot-Marie-Tooth disease
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| PMP22 R157Q | 157 | Cytoplasmic | Uncertain (★) | +7: in a 3D region that tolerates change poorly (1R); R157W at the same position is pathogenic; seen in 3.4e-06 of gnomAD DNA copies; REVEL 0.924 |
| PMP22 T23M | 23 | Transmembrane | Uncertain (★★) | +7: 3 other pathogenic changes within 3 positions; T23K at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.802 |
| MFN2 R104L | 104 | Dynamin-type G | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; R104W at the same position is pathogenic; REVEL 0.945 |
| MFN2 R259H | 259 | Dynamin-type G | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R259L at the same position is pathogenic; REVEL 0.959 |
| LMNA R41L | 41 | IF rod | Conflicting reports (★) | +6: 10 other pathogenic changes within 3 positions; R41C at the same position is pathogenic; REVEL 0.970 |
| LMNA A43T | 43 | IF rod | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; A43E at the same position is pathogenic; REVEL 0.966 |
| MFN2 Q276R | 276 | Dynamin-type G | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; Q276H at the same position is pathogenic; REVEL 0.943 |
| PMP22 M69T | 69 | Transmembrane | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; M69K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.76 |
| LMNA D446G | 446 | LTD | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; D446V at the same position is pathogenic; REVEL 0.981 |
| LMNA T528M | 528 | LTD | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; T528K at the same position is pathogenic; REVEL 0.889 |
| MFN2 E744G | 744 | Part of a helix bundle domain, formed by helices | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; E744D at the same position is pathogenic; REVEL 0.942 |
| LMNA R89H | 89 | IF rod | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; R89G at the same position is pathogenic; REVEL 0.911 |
| PMP22 A67T | 67 | Transmembrane | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; A67P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.76 |
| MFN2 R364L | 364 | Part of a helix bundle domain, formed by helices | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; R364P at the same position is pathogenic; REVEL 0.909 |
| MFN2 E744K | 744 | Part of a helix bundle domain, formed by helices | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; E744D at the same position is pathogenic; REVEL 0.895 |
| MFN2 S231C | 231 | Dynamin-type G | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; S231F at the same position is pathogenic; REVEL 0.902 |
| LMNA R527C | 527 | LTD | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; R527P at the same position is pathogenic; REVEL 0.862 |
| LMNA N456S | 456 | LTD | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; N456K at the same position is pathogenic; REVEL 0.923 |
| LMNA R41S | 41 | IF rod | Conflicting reports (★) | +6: 10 other pathogenic changes within 3 positions; R41C at the same position is pathogenic; REVEL 0.924 |
| MFN2 H242R | 242 | Dynamin-type G | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; H242Y at the same position is pathogenic; REVEL 0.871 |
| MFN2 T362R | 362 | Part of a helix bundle domain, formed by helices | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; T362M at the same position is pathogenic; REVEL 0.804 |
| MFN2 A738T | 738 | Coiled coil | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; A738V at the same position is pathogenic; REVEL 0.859 |
| MFN2 M234V | 234 | Dynamin-type G | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; M234L at the same position is pathogenic; REVEL 0.781 |
| LMNA R527L | 527 | LTD | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; R527P at the same position is pathogenic; REVEL 0.785 |
| LMNA L92V | 92 | IF rod | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; L92P at the same position is pathogenic; REVEL 0.776 |
| LMNA A278T | 278 | IF rod | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; A278P at the same position is pathogenic; REVEL 0.780 |
| LMNA R225Q | 225 | IF rod | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R225P at the same position is pathogenic; REVEL 0.790 |
| MFN2 M376T | 376 | Part of a helix bundle domain, formed by helices | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; M376R at the same position is pathogenic; REVEL 0.923 |
| MFN2 I255M | 255 | Dynamin-type G | Conflicting reports (★) | +6: in a 3D region that tolerates change poorly (3R); I255T at the same position is pathogenic; REVEL 0.825 |
| MFN2 R94P | 94 | Dynamin-type G | Uncertain | +6: 6 other pathogenic changes within 3 positions; R94G at the same position is pathogenic; REVEL 0.982 |
| PMP22 R157G | 157 | Cytoplasmic | Uncertain | +6: in a 3D region that tolerates change poorly (1R); R157W at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 |
| MFN2 D210H | 210 | Dynamin-type G | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; D210G at the same position is pathogenic; REVEL 0.954 |
| MFN2 G127D | 127 | Dynamin-type G | Uncertain | +6: 2 other pathogenic changes within 3 positions; G127R at the same position is pathogenic; REVEL 0.937 |
| MFN2 V273M | 273 | Dynamin-type G | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; V273G at the same position is pathogenic; REVEL 0.914 |
| MFN2 G127V | 127 | Dynamin-type G | Uncertain | +6: 2 other pathogenic changes within 3 positions; G127R at the same position is pathogenic; REVEL 0.904 |
| MFN2 L724R | 724 | Coiled coil | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; L724P at the same position is pathogenic; REVEL 0.966 |
| MFN2 T105R | 105 | Dynamin-type G | Uncertain | +6: 5 other pathogenic changes within 3 positions; T105M at the same position is pathogenic; REVEL 0.964 |
| MFN2 R649H | 649 | Cytoplasmic | Uncertain (★★) | +6: R649P at the same position is pathogenic; REVEL 0.946 |
| MFN2 V273E | 273 | Dynamin-type G | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; V273G at the same position is pathogenic; REVEL 0.955 |
| MFN2 F240I | 240 | Dynamin-type G | Uncertain | +6: 4 other pathogenic changes within 3 positions; F240V at the same position is pathogenic; REVEL 0.963 |
Which prediction tools work for Charcot-Marie-Tooth disease
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 97 out of 100
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 91 out of 100
- ESM1b (LLR): 89 out of 100
- EVE: 88 out of 100
- VARITY: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 84 out of 100
- phyloP: 81 out of 100
- phastCons: 71 out of 100
- Pangolin: 49 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 46 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Dilated cardiomyopathy also has ClinVar records linked to LMNA variants; they fall in the same places as the Charcot-Marie-Tooth disease variants (21 pathogenic / likely pathogenic).
- Familial partial lipodystrophy, Dunnigan type also has ClinVar records linked to LMNA variants; they fall in the same places as the Charcot-Marie-Tooth disease variants (13 pathogenic / likely pathogenic).
- Emery-Dreifuss muscular dystrophy also has ClinVar records linked to LMNA variants; they fall in the same places as the Charcot-Marie-Tooth disease variants (12 pathogenic / likely pathogenic).
- Muscular dystrophy due to LMNA mutation also has ClinVar records linked to LMNA variants; they fall in the same places as the Charcot-Marie-Tooth disease variants (11 pathogenic / likely pathogenic).
- Hutchinson-Gilford syndrome also has ClinVar records linked to LMNA variants; they fall partly in the same places as the Charcot-Marie-Tooth disease variants (9 pathogenic / likely pathogenic).
- Charcot-Marie-Tooth disease, axonal also has ClinVar records linked to MFN2 variants; they fall partly in the same places as the Charcot-Marie-Tooth disease variants (9 pathogenic / likely pathogenic).
- Charcot-Marie-Tooth Neuropathy X also has ClinVar records linked to GJB1 variants; they fall in the same places as the Charcot-Marie-Tooth disease variants (90 pathogenic / likely pathogenic).
- Amyloidosis, hereditary systemic also has ClinVar records linked to TTR variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (101 pathogenic / likely pathogenic).
- Carpal tunnel syndrome also has ClinVar records linked to TTR variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (8 pathogenic / likely pathogenic).
- Hyperthyroxinemia, dystransthyretinemic also has ClinVar records linked to TTR variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (7 pathogenic / likely pathogenic).
- Inclusion body myopathy with Paget disease of bone and frontotemporal dementia also has ClinVar records linked to VCP variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (31 pathogenic / likely pathogenic).
- Frontotemporal dementia and/or amyotrophic lateral sclerosis also has ClinVar records linked to VCP variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (30 pathogenic / likely pathogenic).
- Childhood Onset VCP-related Neurodevelopmental Disorder also has ClinVar records linked to VCP variants; they fall mostly in different places as the Charcot-Marie-Tooth disease variants (4 pathogenic / likely pathogenic).
Diseases related to Charcot-Marie-Tooth disease
- Peripheral neuropathy, also linked to GJB1, KIF5A and MFN2
- Amyotrophic lateral sclerosis, also linked to KIF5A and VCP
- Auditory neuropathy, also linked to KIF5A and MFN2
- Hereditary spastic paraplegia, also linked to KIF5A
- Alzheimer disease, also linked to VCP
- Dilated cardiomyopathy, also linked to LMNA
- Amyloidosis, hereditary systemic, also linked to TTR
- Bethlem myopathy, also linked to LMNA
- Limb-girdle muscular dystrophy, also linked to LMNA
- Charcot-Marie-Tooth Neuropathy X, also linked to GJB1
- Primary dilated cardiomyopathy, also linked to LMNA
- Ovarian cancer, also linked to NTRK1
Frequently asked questions
Which genes have records linked to Charcot-Marie-Tooth disease?
This view contains 8 analyzed proteins: LMNA, MFN2, GJB1, PMP22, TTR and 3 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 321 pathogenic or likely pathogenic variants, 1,085 variants of uncertain significance and 214 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 57 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,772 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center